Compounding Pharmacy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapeutic Area (Pain Management, Hormone Replacement, Dermal Disorders, Nutritional Supplements, Other Therapeutic Areas), By Route of Administration (Oral, Topical, Parenteral, Other Route of Administrations), By End User (Humans, Veterinary) By Region and Competition, 2020-2030F
The Global Compounding Pharmacy Market, valued at USD 12.98 Billion in 2024, is projected to experience a CAGR of 6.52% to reach USD 18.96 Billion by 2030. The global compounding pharmacy market encompasses the specialized practice of pharmacists creating tailored medications for individual patients, addressing unique therapeutic requirements that are not fulfilled by mass-produced pharmaceuticals. This customization may involve specific dosage forms, allergen removal, or enhanced palatability.
Key Market Drivers
The increasing demand for personalized medication is a primary catalyst for the Global Compounding Pharmacy Market. Patients frequently require pharmaceutical formulations precisely adjusted for specific allergies, unique dosage strengths, or alternative administration routes not commercially available. This customization is crucial for optimizing therapeutic outcomes and minimizing adverse reactions, driving demand for tailored solutions. According to the Alliance for Pharmacy Compounding, in their "2023-2024 Compounding Pharmacy Snapshot" published in July 2024, in the median hybrid pharmacy, 30% of all prescriptions were for compounded medications, demonstrating significant reliance on individualized preparations.
Key Market Challenges
The stringent and evolving regulatory environment presents a significant challenge to the global compounding pharmacy market. Varying jurisdictional oversight and complex compliance requirements for quality assurance and safety impose considerable operational complexities and financial burdens on compounding pharmacies. These escalating demands directly impede market expansion by increasing operating costs and diverting resources from potential growth initiatives. For instance, according to the Alliance for Pharmacy Compounding, in Fall 2023, 15% of all surveyed compounding pharmacies ceased hazardous drug compounding due to compliance costs associated with new USP Chapter <800> standards.
Key Market Trends
Advanced Compounding Technology Integration is a key driver for market growth, emphasizing the adoption of automation, robotics, and sophisticated software within compounding pharmacies. This integration aims to enhance precision, reduce the potential for human error, and improve overall operational efficiency, which is crucial for handling complex formulations and increasing production volumes while adhering to stringent quality standards. This trend supports pharmacies in meeting the evolving demands for customized medications. According to the Alliance for Pharmacy Compounding's demographic survey in Fall 2023, 529 unique 503A compounding pharmacies or 503B outsourcing facilities were represented, underscoring the significant number of entities potentially benefiting from these technological advancements.
Key Market Players
In this report, the Global Compounding Pharmacy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies presents in the Global Compounding Pharmacy Market.
Available Customizations:
Global Compounding Pharmacy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Key Market Drivers
The increasing demand for personalized medication is a primary catalyst for the Global Compounding Pharmacy Market. Patients frequently require pharmaceutical formulations precisely adjusted for specific allergies, unique dosage strengths, or alternative administration routes not commercially available. This customization is crucial for optimizing therapeutic outcomes and minimizing adverse reactions, driving demand for tailored solutions. According to the Alliance for Pharmacy Compounding, in their "2023-2024 Compounding Pharmacy Snapshot" published in July 2024, in the median hybrid pharmacy, 30% of all prescriptions were for compounded medications, demonstrating significant reliance on individualized preparations.
Key Market Challenges
The stringent and evolving regulatory environment presents a significant challenge to the global compounding pharmacy market. Varying jurisdictional oversight and complex compliance requirements for quality assurance and safety impose considerable operational complexities and financial burdens on compounding pharmacies. These escalating demands directly impede market expansion by increasing operating costs and diverting resources from potential growth initiatives. For instance, according to the Alliance for Pharmacy Compounding, in Fall 2023, 15% of all surveyed compounding pharmacies ceased hazardous drug compounding due to compliance costs associated with new USP Chapter <800> standards.
Key Market Trends
Advanced Compounding Technology Integration is a key driver for market growth, emphasizing the adoption of automation, robotics, and sophisticated software within compounding pharmacies. This integration aims to enhance precision, reduce the potential for human error, and improve overall operational efficiency, which is crucial for handling complex formulations and increasing production volumes while adhering to stringent quality standards. This trend supports pharmacies in meeting the evolving demands for customized medications. According to the Alliance for Pharmacy Compounding's demographic survey in Fall 2023, 529 unique 503A compounding pharmacies or 503B outsourcing facilities were represented, underscoring the significant number of entities potentially benefiting from these technological advancements.
Key Market Players
- Wedgewood Pharmacy
- B. Braun Medical Inc.
- Fagron NV
- Fresenius Kabi
- Clinigen Group PLC
- Dougherty's Pharmacy, Inc.
- Lorraine's Pharmacy
- Rx3 Compounding Pharmacy
- Institutional Pharmacy Solutions
- Mcguff compounding pharmacy services
In this report, the Global Compounding Pharmacy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Compounding Pharmacy Market, By Therapeutic Area:
- Pain Management
- Hormone Replacement
- Dermal Disorders
- Nutritional Supplements
- Other Therapeutic Areas
- Compounding Pharmacy Market, By Route of Administration:
- Oral
- Topical
- Parenteral
- Other Route of Administrations
- Compounding Pharmacy Market, By End User:
- Humans
- Veterinary
- Compounding Pharmacy Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies presents in the Global Compounding Pharmacy Market.
Available Customizations:
Global Compounding Pharmacy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL COMPOUNDING PHARMACY MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Therapeutic Area (Pain Management, Hormone Replacement, Dermal Disorders, Nutritional Supplements, Other Therapeutic Areas)
5.2.2. By Route of Administration (Oral, Topical, Parenteral, Other Route of Administrations)
5.2.3. By End User (Humans, Veterinary)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. NORTH AMERICA COMPOUNDING PHARMACY MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Therapeutic Area
6.2.2. By Route of Administration
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Compounding Pharmacy Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Therapeutic Area
6.3.1.2.2. By Route of Administration
6.3.1.2.3. By End User
6.3.2. Canada Compounding Pharmacy Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Therapeutic Area
6.3.2.2.2. By Route of Administration
6.3.2.2.3. By End User
6.3.3. Mexico Compounding Pharmacy Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Therapeutic Area
6.3.3.2.2. By Route of Administration
6.3.3.2.3. By End User
7. EUROPE COMPOUNDING PHARMACY MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Therapeutic Area
7.2.2. By Route of Administration
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Compounding Pharmacy Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Therapeutic Area
7.3.1.2.2. By Route of Administration
7.3.1.2.3. By End User
7.3.2. France Compounding Pharmacy Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Therapeutic Area
7.3.2.2.2. By Route of Administration
7.3.2.2.3. By End User
7.3.3. United Kingdom Compounding Pharmacy Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Therapeutic Area
7.3.3.2.2. By Route of Administration
7.3.3.2.3. By End User
7.3.4. Italy Compounding Pharmacy Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Therapeutic Area
7.3.4.2.2. By Route of Administration
7.3.4.2.3. By End User
7.3.5. Spain Compounding Pharmacy Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Therapeutic Area
7.3.5.2.2. By Route of Administration
7.3.5.2.3. By End User
8. ASIA PACIFIC COMPOUNDING PHARMACY MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Therapeutic Area
8.2.2. By Route of Administration
8.2.3. By End User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Compounding Pharmacy Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Therapeutic Area
8.3.1.2.2. By Route of Administration
8.3.1.2.3. By End User
8.3.2. India Compounding Pharmacy Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Therapeutic Area
8.3.2.2.2. By Route of Administration
8.3.2.2.3. By End User
8.3.3. Japan Compounding Pharmacy Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Therapeutic Area
8.3.3.2.2. By Route of Administration
8.3.3.2.3. By End User
8.3.4. South Korea Compounding Pharmacy Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Therapeutic Area
8.3.4.2.2. By Route of Administration
8.3.4.2.3. By End User
8.3.5. Australia Compounding Pharmacy Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Therapeutic Area
8.3.5.2.2. By Route of Administration
8.3.5.2.3. By End User
9. MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Therapeutic Area
9.2.2. By Route of Administration
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Compounding Pharmacy Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Therapeutic Area
9.3.1.2.2. By Route of Administration
9.3.1.2.3. By End User
9.3.2. UAE Compounding Pharmacy Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Therapeutic Area
9.3.2.2.2. By Route of Administration
9.3.2.2.3. By End User
9.3.3. South Africa Compounding Pharmacy Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Therapeutic Area
9.3.3.2.2. By Route of Administration
9.3.3.2.3. By End User
10. SOUTH AMERICA COMPOUNDING PHARMACY MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Therapeutic Area
10.2.2. By Route of Administration
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Compounding Pharmacy Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Therapeutic Area
10.3.1.2.2. By Route of Administration
10.3.1.2.3. By End User
10.3.2. Colombia Compounding Pharmacy Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Therapeutic Area
10.3.2.2.2. By Route of Administration
10.3.2.2.3. By End User
10.3.3. Argentina Compounding Pharmacy Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Therapeutic Area
10.3.3.2.2. By Route of Administration
10.3.3.2.3. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL COMPOUNDING PHARMACY MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Wedgewood Pharmacy
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. B. Braun Medical Inc.
15.3. Fagron NV
15.4. Fresenius Kabi
15.5. Clinigen Group PLC
15.6. Dougherty's Pharmacy, Inc.
15.7. Lorraine's Pharmacy
15.8. Rx3 Compounding Pharmacy
15.9. Institutional Pharmacy Solutions
15.10. Mcguff compounding pharmacy services
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL COMPOUNDING PHARMACY MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Therapeutic Area (Pain Management, Hormone Replacement, Dermal Disorders, Nutritional Supplements, Other Therapeutic Areas)
5.2.2. By Route of Administration (Oral, Topical, Parenteral, Other Route of Administrations)
5.2.3. By End User (Humans, Veterinary)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. NORTH AMERICA COMPOUNDING PHARMACY MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Therapeutic Area
6.2.2. By Route of Administration
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Compounding Pharmacy Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Therapeutic Area
6.3.1.2.2. By Route of Administration
6.3.1.2.3. By End User
6.3.2. Canada Compounding Pharmacy Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Therapeutic Area
6.3.2.2.2. By Route of Administration
6.3.2.2.3. By End User
6.3.3. Mexico Compounding Pharmacy Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Therapeutic Area
6.3.3.2.2. By Route of Administration
6.3.3.2.3. By End User
7. EUROPE COMPOUNDING PHARMACY MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Therapeutic Area
7.2.2. By Route of Administration
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Compounding Pharmacy Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Therapeutic Area
7.3.1.2.2. By Route of Administration
7.3.1.2.3. By End User
7.3.2. France Compounding Pharmacy Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Therapeutic Area
7.3.2.2.2. By Route of Administration
7.3.2.2.3. By End User
7.3.3. United Kingdom Compounding Pharmacy Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Therapeutic Area
7.3.3.2.2. By Route of Administration
7.3.3.2.3. By End User
7.3.4. Italy Compounding Pharmacy Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Therapeutic Area
7.3.4.2.2. By Route of Administration
7.3.4.2.3. By End User
7.3.5. Spain Compounding Pharmacy Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Therapeutic Area
7.3.5.2.2. By Route of Administration
7.3.5.2.3. By End User
8. ASIA PACIFIC COMPOUNDING PHARMACY MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Therapeutic Area
8.2.2. By Route of Administration
8.2.3. By End User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Compounding Pharmacy Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Therapeutic Area
8.3.1.2.2. By Route of Administration
8.3.1.2.3. By End User
8.3.2. India Compounding Pharmacy Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Therapeutic Area
8.3.2.2.2. By Route of Administration
8.3.2.2.3. By End User
8.3.3. Japan Compounding Pharmacy Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Therapeutic Area
8.3.3.2.2. By Route of Administration
8.3.3.2.3. By End User
8.3.4. South Korea Compounding Pharmacy Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Therapeutic Area
8.3.4.2.2. By Route of Administration
8.3.4.2.3. By End User
8.3.5. Australia Compounding Pharmacy Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Therapeutic Area
8.3.5.2.2. By Route of Administration
8.3.5.2.3. By End User
9. MIDDLE EAST & AFRICA COMPOUNDING PHARMACY MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Therapeutic Area
9.2.2. By Route of Administration
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Compounding Pharmacy Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Therapeutic Area
9.3.1.2.2. By Route of Administration
9.3.1.2.3. By End User
9.3.2. UAE Compounding Pharmacy Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Therapeutic Area
9.3.2.2.2. By Route of Administration
9.3.2.2.3. By End User
9.3.3. South Africa Compounding Pharmacy Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Therapeutic Area
9.3.3.2.2. By Route of Administration
9.3.3.2.3. By End User
10. SOUTH AMERICA COMPOUNDING PHARMACY MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Therapeutic Area
10.2.2. By Route of Administration
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Compounding Pharmacy Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Therapeutic Area
10.3.1.2.2. By Route of Administration
10.3.1.2.3. By End User
10.3.2. Colombia Compounding Pharmacy Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Therapeutic Area
10.3.2.2.2. By Route of Administration
10.3.2.2.3. By End User
10.3.3. Argentina Compounding Pharmacy Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Therapeutic Area
10.3.3.2.2. By Route of Administration
10.3.3.2.3. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL COMPOUNDING PHARMACY MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Wedgewood Pharmacy
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. B. Braun Medical Inc.
15.3. Fagron NV
15.4. Fresenius Kabi
15.5. Clinigen Group PLC
15.6. Dougherty's Pharmacy, Inc.
15.7. Lorraine's Pharmacy
15.8. Rx3 Compounding Pharmacy
15.9. Institutional Pharmacy Solutions
15.10. Mcguff compounding pharmacy services
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
